EverHint Signal — EMA10 × EMA30 Crossover — Swing Trading Setup - November 12, 2025
November 12, 2025
(Filters applied: RSI ≥ 50, Price ≥ SMA200, Price ≥ $10)
What this signal is (quick)
We’re testing a fast momentum crossover: the 10-day Exponential Moving Average (EMA10) moving above or below the 30-day Exponential Moving Average (EMA30).
- EMA10 > EMA30 → “Buy” — short-term momentum overtakes the 1-month trend (early bullish inflection).
- EMA10 < EMA30 → “Sell” — short-term momentum slips under the 1-month trend (early weakness).
Because EMAs react faster than SMAs, this can catch early trend changes—but it’s prone to whipsaws in sideways markets.
Today’s signals use end-of-day data for November 12, 2025, and this scanner remains experimental while we refine performance tracking.
How we ranked today (reader version)
- Trend posture: fresh EMA10/EMA30 cross on the daily close (with RSI/SMA200/$10 filters).
- Overlays: 90-day insider net flows (open-market buys – sells), days → next earnings, and a recent analyst-estimate snapshot.
- Headlines: most recent corporate news to confirm or challenge the move.
Signals are for educational use and back-testing only.
📈 Buy-Side Signals — EMA10×EMA30 (up-cross) — Filtered list
| Rank | Ticker | Sector | Last ($) | RSI (14) | Insider Net (USD) | Days → Earnings |
|---|---|---|---|---|---|---|
| 1 | ALL | Financial Services | 209.21 | 78.4 | -39,497 | 84 |
| 2 | HALO | Healthcare | 70.63 | 70.8 | -106,256 | |
| 3 | ACGL | Financial Services | 91.78 | 69.5 | -941,463 | 89 |
| 4 | EGO | Basic Materials | 28.89 | 68.4 | ||
| 5 | SSNC | Technology | 85.25 | 68.1 | 85 | |
| 6 | UBSI | Financial Services | 36.49 | 67.8 | ||
| 7 | PFE | Healthcare | 34.12 | 66.9 | ||
| 8 | ORI | Financial Services | 33.41 | 66.2 | ||
| 9 | SBSW | Basic Materials | 11.63 | 65.7 | ||
| 10 | DGX | Healthcare | 186.85 | 61.9 | ||
| 11 | NVS | Healthcare | 116.73 | 60.7 |
Field notes
Insider Net (USD) = open-market purchases − sales in last 90 days.
Days → Earnings = distance to next known report.
Recent Headlines (context)
- ALL (Allstate) — Reported Q3 results Nov 5; investor materials posted. (Allstate Investors)
- HALO (Halozyme) — Stock strength follows Q3 beat; also priced $1.3B of convertible notes expected to close Nov 12; CEO filed recent sales. (Investors.com)
- ACGL (Arch Capital) — Shares extended a multi-session advance today; fund-flow headlines note fresh institutional buys. (MarketWatch)
- EGO (Eldorado Gold) — New 13G/A shows VanEck at ~8.16% ownership; small-cap fund items note positioning. (Stock Titan)
- SSNC (SS&C Tech) — Announced acquisition of Curo Fund Services Nov 12; strategy pieces track AI agent rollout. (investor.ssctech.com)
- UBSI (United Bankshares) — Recent filings highlight increased institutional stakes. (MarketBeat)
- PFE (Pfizer) — Commentary highlights valuation debate and updated EPS expectations in sell-side tallies. (Yahoo Finance)
- ORI (Old Republic) — Coverage notes additional institutional purchases. (MarketBeat)
- DGX (Quest Diagnostics) — Underperformed peers in today’s session after a short winning streak. (MarketWatch)
📉 Sell-Side Signals — EMA10×EMA30 (down-cross)
(None met the RSI/SMA200/$10 filters today.)
Vlad’s Take (EverHint)
- Rotation snapshot: The stricter swing filters concentrate Financials and Healthcare on the buy list, with Tech entries tied to specific catalysts (M&A/AI initiatives).
- Tactics for fast crossovers:
- Confirm with 2–3 closes beyond the 10/30 band.
- Trim into RSI > 70 surges; consider covers or partial buys near RSI < 30 washes.
- Use ATR-aware stops anchored to recent swing levels rather than the EMAs themselves.
Independent research. No hype, no pumps, no paid promotions — just clean, data-driven signals and concise context.